Literature DB >> 23791475

Immunolocalization of Wilms' Tumor protein (WT1) in developing human peripheral sympathetic and gastroenteric nervous system.

Rosalba Parenti1, Lidia Puzzo2, Giada Maria Vecchio2, Lucia Gravina1, Lucia Salvatorelli2, Giuseppe Musumeci3, Enrico Vasquez2, Gaetano Magro4.   

Abstract

Developmental expression of Wilms' tumor gene (WT1) and protein is crucial for cell proliferation, apoptosis, differentiation and cytoskeletal architecture regulation. Recently, a potential role of WT1 has been suggested in the development of neural tissue and in neurodegenerative disorders. We have investigated immunohistochemically the developmentally regulated expression and distribution of WT1 in the human fetal peripheral sympathetic nervous system (PSNS) and the gastro-enteric nervous system (GENS) from weeks 8 to 28 gestational age. WT1 expression was restricted to the cytoplasm of sympathetic neuroblasts, while it progressively disappeared with advancing morphologic differentiation of these cells along both ganglionic and chromaffin cell lineages. In adult tissues, both ganglion and chromaffin cells lacked any WT1 expression. These findings show that WT1 is a reliable marker of human sympathetic neuroblasts, which can be used routinely in formalin-fixed, paraffin-embedded tissues. The progressive loss of WT1 in both ganglion and chromaffin cells, suggests its potential repressor role of differentiation in a precise temporal window during the development of the human PSNS and GENS.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cytoplasmic immunostaining; Human fetus; Immunohistochemistry; Sympathetic peripheral nervous system; WT1; Wilms’ tumor gene

Mesh:

Substances:

Year:  2013        PMID: 23791475     DOI: 10.1016/j.acthis.2013.05.003

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  11 in total

1.  WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.

Authors:  Caroline Masserot; Qingyuan Liu; Eric Nguyen; Charles-Henry Gattolliat; Dominique Valteau-Couanet; Jean Bénard; Catherine Huber; Evelyne Ségal-Bendirdjian
Journal:  Mol Oncol       Date:  2015-10-21       Impact factor: 6.603

2.  WT1 expression in the human fetus during development.

Authors:  R Ambu; L Vinci; C Gerosa; D Fanni; E Obinu; A Faa; V Fanos
Journal:  Eur J Histochem       Date:  2015-06-29       Impact factor: 3.188

3.  Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.

Authors:  Rosalba Parenti; Venera Cardile; Adriana Carol Eleonora Graziano; Carmela Parenti; Assunta Venuti; Maria Paola Bertuccio; Debora Lo Furno; Gaetano Magro
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

4.  Expression profile of Wilms Tumor 1 (WT1) isoforms in undifferentiated and all-trans retinoic acid differentiated neuroblastoma cells.

Authors:  Grazia Maugeri; Agata Grazia D'Amico; Daniela Maria Rasà; Rita Reitano; Salvatore Saccone; Concetta Federico; Rosalba Parenti; Gaetano Magro; Velia D'Agata
Journal:  Genes Cancer       Date:  2016-01

5.  Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation.

Authors:  Adriana Carol Eleonora Graziano; Venera Cardile; Rosanna Avola; Nunzio Vicario; Carmela Parenti; Lucia Salvatorelli; Gaetano Magro; Rosalba Parenti
Journal:  Oncotarget       Date:  2017-02-21

6.  Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms' Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49).

Authors:  Dorin Novacescu; Talida Georgiana Cut; Alin Adrian Cumpanas; Silviu Constantin Latcu; Razvan Bardan; Ovidiu Ferician; Cosmin-Ciprian Secasan; Andrei Rusmir; Marius Raica
Journal:  Biomedicines       Date:  2022-04-15

Review 7.  Connexins Signatures of the Neurovascular Unit and Their Physio-Pathological Functions.

Authors:  Nunzio Vicario; Rosalba Parenti
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

8.  Immunohistochemical markers of neural progenitor cells in the early embryonic human cerebral cortex.

Authors:  L Vinci; A Ravarino; V Fanos; A G Naccarato; G Senes; C Gerosa; G Bevilacqua; G Faa; R Ambu
Journal:  Eur J Histochem       Date:  2016-02-01       Impact factor: 3.188

9.  Novel WT1 Target Genes: IL-2, IL-2RB, and IL-2RG Discovered during WT1 Silencing Using Lentiviral-Based RNAi in Myeloid Leukemia Cells.

Authors:  Duangnapa Dejjuy; Chavaboon Dechsukhum; Kovit Pattanapanyasat; Egarit Noulsri; Gregory A Dissen; Wilairat Leeanansaksiri
Journal:  Biomed Res Int       Date:  2020-10-14       Impact factor: 3.411

10.  WT1 and Cyclin D1 Immunohistochemistry: A Useful Adjunct for Diagnosis of Pediatric Small Round Blue Cell Tumors on Small Biopsies.

Authors:  Lucia Salvatorelli; Rosalba Parenti; Giuseppe Broggi; Giada Maria Vecchio; Giuseppe Angelico; Lidia Puzzo; Andrea Di Cataldo; Vincenzo Di Benedetto; Rita Alaggio; Gaetano Magro
Journal:  Diagnostics (Basel)       Date:  2021-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.